{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T22:55:39Z","timestamp":1788648939144,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"crossref","award":["ZYGD18011"],"award-info":[{"award-number":["ZYGD18011"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"crossref","award":["ZY2016104"],"award-info":[{"award-number":["ZY2016104"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"crossref","award":["ZYJC18015"],"award-info":[{"award-number":["ZYJC18015"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project of Science and Technology Department of Sichuan Province","award":["2018SZ0118"],"award-info":[{"award-number":["2018SZ0118"]}]},{"name":"Project of Sichuan Provincial Health Department","award":["ChuanGanYan-ZH2017-101"],"award-info":[{"award-number":["ChuanGanYan-ZH2017-101"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.urolonc.2020.02.020","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T07:40:24Z","timestamp":1586158824000},"page":"574-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Concomitant carcinoma in situ as a prognostic factor in the upper tract urothelial carcinoma after radical nephroureterectomy: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"38","author":[{"given":"Xiaoshuai","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.02.020_bib0001","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","article-title":"Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract","volume":"57","author":"Zigeuner","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0002","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4143\/crt.2017.417","article-title":"The comparison of oncologic outcomes between open and laparoscopic radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: a Korean Multicenter Collaborative Study","volume":"51","author":"Kim","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0003","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0004","doi-asserted-by":"crossref","unstructured":"Cho YH, Hwang JE, Chung HS, Kim MS, Hwang EC. The De Ritis (aspartate transaminase\/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma. 2017; 49:1383\u201390. doi:10.1007\/s11255-017-1613-z","DOI":"10.1007\/s11255-017-1613-z"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0005","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.18632\/oncotarget.10708","article-title":"Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0006","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jjco\/hyy084","article-title":"Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma","volume":"48","author":"Kohada","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0007","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.urolonc.2010.01.001","article-title":"Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy","volume":"30","author":"Wheat","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0008","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00345-011-0645-8","article-title":"Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients","volume":"29","author":"Otto","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0009","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/j.clgc.2016.04.017","article-title":"Histopathologic characteristics of upper tract urothelial carcinoma with an emphasis on their effect on cancer survival: a single-institute experience with 305 patients with long-term follow-up","volume":"14","author":"Elawdy","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0010","unstructured":"Wells G, Shea B, O'Connell D et al. The Newcasstle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analysis\u0f0e Available at:http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed: September 4, 2019."},{"key":"10.1016\/j.urolonc.2020.02.020_bib0011","unstructured":"Phillips B, Ball C, Sackett D et al. Oxford Centre for Evidence Based Medicine\u2014levels of evidence (March 2009). Centre for Evidence-Based Medicine. Available at:http:\/\/www.cebm.net\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/. Accessed: September 4, 2019."},{"key":"10.1016\/j.urolonc.2020.02.020_bib0012","series-title":"Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study","author":"Aydin","year":"2019"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0013","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1464-410X.2012.11474.x","article-title":"Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration","volume":"112","author":"Fairey","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0014","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00345-016-1835-1","article-title":"Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study","volume":"35","author":"Favaretto","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0015","first-page":"7203","article-title":"Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma","volume":"8","author":"Makise","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0016","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00345-013-1141-0","article-title":"Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"32","author":"Masson-Lecomte","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0017","doi-asserted-by":"crossref","unstructured":"Su X, Fang D, Li X. The influence of tumor size on oncologic outcomes for patients with upper tract urothelial carcinoma after radical nephroureterectomy. 2016; 2016:4368943. doi:10.1155\/2016\/4368943","DOI":"10.1155\/2016\/4368943"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0018","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","article-title":"Upper tract urothelial neoplasms: incidence and survival during the last 2 decades","volume":"164","author":"Munoz","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.02.020_bib0019","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.eururo.2008.01.006","article-title":"Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors","volume":"53","author":"Zigeuner","year":"2008","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920300612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920300612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:16:54Z","timestamp":1761041814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920300612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1078143920300612"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.02.020","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concomitant carcinoma in situ as a prognostic factor in the upper tract urothelial carcinoma after radical nephroureterectomy: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}